Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 12, 2012 - Issue 2
Submit an article Journal homepage
97
Views
1
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

Patient preferences for psoriasis treatment: process characteristics considered more important than outcome attributes

Fiona Meredith Department of Dermatology, Ward 29, Aberdeen Royal Infirmary, Foresterhill, Aberdeen, AB25 2ZN, Scotland, UK; Department of Dermatology, Ward 29, Aberdeen Royal Infirmary, Foresterhill, Aberdeen, AB25 2ZN, Scotland, UK
&
Anthony D Ormerod Division of Applied Medicine, University of Aberdeen, Polwarth Building, Foresterhill Road, Aberdeen, AB25 2ZD, Scotland, UK. [email protected]; Division of Applied Medicine, University of Aberdeen, Polwarth Building, Foresterhill Road, Aberdeen, AB25 2ZD, Scotland, UK. [email protected]
Pages 145-147 | Published online: 09 Jan 2014

References

  • Schaarschmidt ML, Schmieder A, Umar N et al. Patient preferences for psoriasis treatments. Process characteristics can outweigh outcome attributes. Arch. Dermatol.147(11), 1285–1294 (2011).
  • Ashcroft DM, Seston E, Griffiths CE. Trade-offs between the benefits and risks of drug treatment for psoriasis: a discrete choice experiment with U.K. dermatologists. Br. J. Dermatol.155(6), 1236–1241 (2006).
  • Seston EM, Ashcroft DM, Griffiths CEM. Balancing the benefits and risks of drug treatment. A stated-preference, discrete choice experiment with patients with psoriasis. Arch. Dermatol.143(9), 1175–1179 (2007).
  • Delfino M, Holt EW, Taylor CR, Wittenberg E, Qureshi AA. Willingness-to-pay stated preferences for 8 health related quality-of-life domains in psoriasis: a pilot study. J. Am. Acad. Dermatol.59(3), 439–447 (2008).
  • Schmieder A, Schaarschmidt ML, Umar N et al. Comorbidities significantly impact patients’ preference for psoriasis treatments. J. Am. Acad. Dermatol. doi:10.1016/j.jaad.2011.08.023 (2011) (Epub ahead of print).
  • Schaarschmidt ML, Umar N, Schmieder A et al. Patient preference for psoriasis treatments: impact of treatment experience. J. Eur. Acad. Dermatol. Venereol. doi:10.1111/j.1468–3083.2011.04440 (2012) (Epub ahead of print).
  • Chan SA, Hussain F, Lawson LG, Ormerod AD. Factors affecting adherence to treatment of psoriasis: comparing biologic therapy to other modalities. J. Derm. Treat. doi:10.3109/09546634.2011.607425 (2011) (Epub ahead of print).
  • Lecluse LLA, Tutein Nolthenius JLE, Bos JD, Spuls PI. Patient preference and satisfaction with systemic therapies for psoriasis: an area to be explored. Br. J. Dermatol.160(6), 1340–1343 (2009).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.